|
| |
Rad51 RecombinaseDownload PDF containing detailed information.
Recent Publications on Rad51 Recombinase: |  |
Regulation of meiotic recombination via Mek1-mediated Rad54 phosphorylation.
A preference for homologs over sister chromatids in homologous... | 18th November, 2009
| Department of Biochemistry and Cell Biology, Stony Brook University, Stony
| Mol Cell. 2009 Nov 13;36(3):393-404.
DOI Direct Link |
Involvement of a chromatin remodeling complex in damage tolerance during DNA replication.
ATP-dependent chromatin remodeling complexes have been shown to... | 18th November, 2009
| Department of Carcinogenesis, Science Park Research Division, MD Anderson
| Nat Struct Mol Biol. 2009 Nov;16(11):1167-72. Epub 2009 Oct 25.
DOI Direct Link |
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.
Smad4 is a central mediator of TGF-beta signaling, and its expression is... | 18th November, 2009
| Department of Otolaryngology, Oregon Health & Science University (OHSU),
| J Clin Invest. 2009 Nov;119(11):3408-19. doi: 10.1172/JCI38854. Epub 2009
DOI Direct Link |
Bloom syndrome helicase stimulates RAD51 DNA strand exchange activity through a novel mechanism.
Loss or inactivation of BLM, a helicase of the RecQ family, causes Bloom... | 7th November, 2009
| Department of Biochemistry and Molecular Biology, Drexel University
| J Biol Chem. 2009 Sep 25;284(39):26349-59. Epub 2009 Jul 24.
DOI Direct Link |
Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.
The breast and ovarian cancer suppressor protein BRCA2 controls the RAD51... | 31st October, 2009
| The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research
| Nucleic Acids Res. 2009 Oct 29.
DOI Direct Link |
→View more research publications. |
Press Releases About Rad51 Recombinase:
|
 |
| SuperGen Reports 2008 Third Quarter Financial Results |
4th November, 2008 |
SuperGen, Inc. |
DUBLIN, Calif., Nov. 4 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and
development of novel cancer therapies, today announced
|
| SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy |
23rd October, 2008 |
SuperGen, Inc. |
DUBLIN, Calif., Oct. 23 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and
development of novel cancer therapies, today presented data
|
| SuperGen Granted Orphan Drug Designation for MP-470 in Glioblastoma Multiforme |
7th August, 2008 |
SuperGen, Inc. |
DUBLIN, Calif., Aug. 7 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid
development and commercialization of therapies for solid
|
| SuperGen Reports 2008 Second Quarter Financial Results |
4th August, 2008 |
SuperGen, Inc. |
DUBLIN, Calif., Aug. 4 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid
development and commercialization of therapies for solid
|
BioPortfolio Ltd. offers e-mail and postal lists for Rad51 Recombinase scientists - we have details of around 97 individuals working on Rad51 Recombinase .
This page has been viewed 293 times
Recent Search Terms used to find this page: rad51 recombinase | RAD51 recombinase | rad51 as recombinase | download rad51 | PTEn single strand annealing | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Rad51 Recombinase across BioPortfolio, or for Rad51 Recombinase Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
